Document is current

Article History

Received: 7 November 2016

Accepted: 30 November 2016

First Online: 7 December 2016

Change Date: 28 February 2020

Change Type: Clarification

Change Details: The Editors-in-Chief are currently investigating this article [Mesdaghinia, E., Rahavi, A., Bahmani, F. et al. Clinical and Metabolic Response to Selenium Supplementation in Pregnant Women at Risk for Intrauterine Growth Restriction: Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res 178, 14–21 (2017). https://doi.org/10.1007/s12011-016-0911-0] as concerns have been raised about integrity of the clinical trial reported here. There is also an ongoing investigation by the Iranian National Committee for Ethics in Biomedical Researches. Further editorial action will be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.

Compliance with Ethical Standards

:

: This trial was done according to the guidelines laid down in the Declaration of Helsinki. This study was approved by the ethics committee of Kashan University of Medical Sciences (KUMS) and registered on the Iranian registry of clinical trials website (ExternalRef removed: IRCT201601045623N64). All subjects provided informed written consent before recruitment.

: The authors declare that they have no conflicts of interest.